Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene (ENSG00000250997)** is a genomic region classified as a pseudogene of the MYBL2 gene, and does not encode a functional protein. Pseudogenes are typically inactive remnants of genes that may arise by duplication or retrotransposition, lacking the necessary regulatory elements for transcription and translation[2][4]. Unlike functional MYBL2, which is a transcription factor involved in cell cycle regulation and proliferation, this pseudogene is not considered to have significant biological function or disease relevance. It is not a therapeutic target and is not implicated in pharmacological modulation or used for biomarker analysis[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene.